November 27, 2024 Autosomal Recessive Polycystic Kidney Disease (ARPKD)Adjunct EL-PFDD Scientific Workshop Report The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..
November 27, 2024 Voice of the Patient report Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting for ARPKD Patients and their Families Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...
November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...
November 17, 2024 Advancing Neonatal Drug Development: Celebrating Progress on World Prematurity Day On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize...
November 14, 2024 C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1 Diabetes In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium
November 14, 2024 Advanced in Vitro Modelling of Neuromuscular Diseases and Therapeutics Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering...
November 13, 2024 C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM‑PD) Initiative C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..
November 7, 2024 C-Path Announces Key Leadership Appointments in Neurodegenerative Disease Research Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.
November 6, 2024 The Path to Accessibility: Installing ADA-Friendly Solutions When C-Path launched its new website, it was built to be sleek, mobile, responsive and navigable.
November 5, 2024 C-Path Scientific Directors Belmonte, Kosinski to Present at 20th IDS Congress Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present...